Success Metrics

Completion Rate
0%(0/1)
Active Trials
2(67%)
Terminated
1(33%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Terminated(1)

Detailed Status

Recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
0.0%

Trials by Status

recruiting267%
terminated133%

Recent Activity

2 active trials
Showing 3 of 3
recruiting

Evolution of HIV Reservoir, Inflammation and Microbiota Footprint of PLWH Switching to Long-acting Injectable Treatment Compared to Patients on Oral Dual or Triple Anti-integrase-based Therapy

NCT05303337
recruiting

Microbiota Footprint and Frailty Phenotype in Virologically Suppressed People Living With HIV

NCT05078957
terminated

Antiretroviral Localization in Gut-Associated Lymphoid Tissue and Lower Female Genital Tract Tissue of HIV+ Subjects

NCT02641444

Clinical Trials (3)

Showing 3 of 3 trials
NCT05303337

Evolution of HIV Reservoir, Inflammation and Microbiota Footprint of PLWH Switching to Long-acting Injectable Treatment Compared to Patients on Oral Dual or Triple Anti-integrase-based Therapy

Recruiting
NCT05078957

Microbiota Footprint and Frailty Phenotype in Virologically Suppressed People Living With HIV

Recruiting
NCT02641444

Antiretroviral Localization in Gut-Associated Lymphoid Tissue and Lower Female Genital Tract Tissue of HIV+ Subjects

Terminated

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3